Table 1.

Conflict of interest (COI) reporting by Australian clinical trial authors, January to August 2020

	n (%)
Study reports	120 (100)
All relevant COI declared	64 (53.3)
≥ 1 Australian author with missing or incomplete COI declaration	56 (46.6)
1 author	36 (30.0)
2 authors	13 (10.8)
≥3 authors	7 (5.8)
Authors	323 (100)
All relevant COI declared*	245 (75.9)
≥ 1 undeclared COI	78 (24.1)
Types of inconsistent COI declarations	89 (100)
No declaration of COI	46 (51.7)
Partial declaration (some but not all COI)	39 (43.8)
No named companies**	2 (2.2)
Article includes no COI statement	2 (2.2)
Journals with Australian authors with missing or incomplete COI	32 (100)
ICMJE or stricter COI declaration policies	19 (59.4)
Less strict than ICMJE or vague author guidance	13 (40.6)

*Includes authors with no COI, authors with complete COI disclosure, and non-clinician authors (no data available in the Medicines Australia database) 

**Authors’ COI statements list only “pharmaceutical companies” or “multiple unnamed pharmaceutical companies”, without stating which companies provided funding